<DOC>
	<DOCNO>NCT00712452</DOCNO>
	<brief_summary>The objective evaluate influence chemotherapy , either auto-immune disease , either carcinologic disease , clinical biological marker ovarian reserve , young patient , normal reproductive function .</brief_summary>
	<brief_title>Evaluation Chemotherapy Influence Clinical Biological Markers Ovarian Reserve</brief_title>
	<detailed_description>The study enrol patient 18 35 year , treat neoadjuvant adjuvant chemotherapy systemic lupus erythematosus ( Group 1 ) , breast cancer ( Group 2 ) Hodgkin disease ( Group 3 ) evaluate clinical biological marker ovarian reserve . The follow-up last 24 month patient visit treatment , 3 month , 6 month , one year two year treatment . During period , collect pre post treatment clinical data , biological data ultrasonographic data antral follicle count marker ovarian follicle reserve.These data observe current practice .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Women volunteer treat chemotherapy , ≥ 18 ≤ 35 year old Regular menstrual cyclicity , 25 35 day Social security affiliation Signed informed consent Women &lt; 18 &gt; 35 year old Pregnancy Emergent treatment necessity No social security affiliation Virgin patient</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>fertility</keyword>
	<keyword>chemotherapy</keyword>
</DOC>